265 related articles for article (PubMed ID: 2470342)
1. Regulation of major histocompatibility gene expression in human vascular smooth muscle cells.
Warner SJ; Friedman GB; Libby P
Arteriosclerosis; 1989; 9(3):279-88. PubMed ID: 2470342
[TBL] [Abstract][Full Text] [Related]
2. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
Stemme S; Fager G; Hansson GK
Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
[TBL] [Abstract][Full Text] [Related]
3. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
5. Cryopreserved aortic homografts contain viable smooth muscle cells capable of expressing transplantation antigens.
Salomon RN; Friedman GB; Callow AD; Payne DD; Libby P
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1173-80. PubMed ID: 8246556
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
7. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of ovine alveolar macrophages: regulation of surface antigen expression and cytokine production.
Nash AD; Barcham GJ; Andrews AE; Brandon MR
Vet Immunol Immunopathol; 1992 Feb; 31(1-2):77-94. PubMed ID: 1570684
[TBL] [Abstract][Full Text] [Related]
9. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
[TBL] [Abstract][Full Text] [Related]
10. MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma.
Bander NH; Yao D; Liu H; Chen YT; Steiner M; Zuccaro W; Moy P
Prostate; 1997 Dec; 33(4):233-9. PubMed ID: 9397194
[TBL] [Abstract][Full Text] [Related]
11. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases.
Miller A; Lanir N; Shapiro S; Revel M; Honigman S; Kinarty A; Lahat N
J Neuroimmunol; 1996 Feb; 64(2):151-61. PubMed ID: 8632057
[TBL] [Abstract][Full Text] [Related]
13. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells.
Swerlick RA; Garcia-Gonzalez E; Kubota Y; Xu YL; Lawley TJ
J Invest Dermatol; 1991 Aug; 97(2):190-6. PubMed ID: 1906507
[TBL] [Abstract][Full Text] [Related]
14. Involvement of platelet-derived growth factor and histocompatibility of DRB 1 in chronic renal allograft nephropathy.
Yamada K; Hatakeyama E; Sakamaki T; Nishimura M; Arita S; Sakamoto K; Hamaguchi K; Nakajima K; Otsuka M; Tanabe K
Transplantation; 2001 Apr; 71(7):936-41. PubMed ID: 11349729
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
[TBL] [Abstract][Full Text] [Related]
16. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
[TBL] [Abstract][Full Text] [Related]
17. Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens.
Groenewegen G; de Ley M; Jeunhomme GM; Buurman WA
J Exp Med; 1986 Jul; 164(1):131-43. PubMed ID: 2941512
[TBL] [Abstract][Full Text] [Related]
18. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
Batten P; Yacoub MH; Rose ML
Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
[TBL] [Abstract][Full Text] [Related]
19. Cytokine modulation of costimulatory molecules on human fetal retinal pigment epithelial cells.
Farrokh-Siar L; Rezai KA; Palmer EM; Patel SC; Ernest TJ; van Seventer GA
Curr Eye Res; 2001 Oct; 23(4):285-90. PubMed ID: 11852430
[TBL] [Abstract][Full Text] [Related]
20. Control of the expression of a class II major histocompatibility gene (HLA-DR) in various human cell types: down-regulation by IL-1 but not by IL-6, prostaglandin E2, or glucocorticoids.
Watanabe Y; Lee S; Allison AC
Scand J Immunol; 1990 Dec; 32(6):601-9. PubMed ID: 2125363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
